Skip to main content
HR 5805 113th Congress House Health Administrative law and regulatory procedures Administrative remedies Advisory bodies Congressional oversight Consumer affairs Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug therapy Executive agency funding and structure Food and Drug Administration (FDA) Government information and archives Government studies and investigations Health care coverage and access

Andrea Sloan CURE Act

Introduced: December 8, 2014 Introduced by: McCaul, Michael T. Republican · Texas See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 12, 2014
Referred to the Subcommittee on Health.
Dec 8, 2014
Referred to the House Committee on Energy and Commerce.
Dec 8, 2014
Introduced in House
 Plain-English summary Congressional Research Service

Andrea Sloan Compassionate Use Reform and Enhancement Act or the Andrea Sloan CURE Act - Amends the Federal Food, Drug, and Cosmetic Act to require the sponsor of a “breakthrough drug” (which is a drug that qualifies for expedited approval, is an infectious disease product, or qualifies the sponsor for a priority review voucher) to submit to the Secretary of Health and Human Services (HHS) and make available to the public a policy on requests for access to the drug for compassionate use, including the minimum criteria for consideration or approval of requests and the time needed to make a decision.

Requires a breakthrough drug sponsor to explain a denied request for compassionate use to the person who made the request.

Directs HHS to establish an Expanded Access Task Force. Requires the Task Force and the Government Accountability Office (GAO) to evaluate patient access to investigational drugs and make recommendations for improving access.

Directs HHS to finalize the draft guidance entitled “Expanded Access to Investigational Drugs for Treatment Use--Qs & As,” taking into account reports from the Task Force and GAO.
What's happening now December 12, 2014

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2